Stock Events

Stock Events

Chengdu Olymvax Biopharmaceuticals (688319.SHG) Q4 2023 Earnings

27FebConfirmed

Q3 2022

Q1 2023

Q2 2023

Q4 2023

-0.03

-0.01

0

0.02

Details

Expected EPS

N/A

Actual EPS

N/A

Surprise EPS

0

Surprise Percent

+NaN%

Description

Chengdu Olymvax Biopharmaceuticals (688319.SHG) will report earnings of for Q4 2023 on February 27, 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.